Jessup, MD, United States of America

Mikkel A Algire

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mikkel A. Algire: Innovator in Genome Cloning and Manipulation

Introduction

Mikkel A. Algire is a prominent inventor based in Jessup, MD (US). He has made significant contributions to the field of genetic engineering, particularly in the area of genome cloning and manipulation. With a total of 2 patents, his work has the potential to revolutionize how genomes are handled in various biological applications.

Latest Patents

Mikkel's latest patents focus on innovative methods for cloning and manipulating genomes. The first patent describes compositions and methods for cloning a donor genome in a heterologous host cell. In this embodiment, the donor genome can be further modified within the host cell. Additionally, modified or unmodified genomes can be isolated from the host cell and transferred to a recipient cell. This method can be particularly useful for altering donor genomes from intractable donor cells into more tractable host cells. The second patent similarly outlines methods for cloning a synthetic or semi-synthetic donor genome in a heterologous host cell, emphasizing the versatility and applicability of his techniques.

Career Highlights

Mikkel A. Algire is currently associated with Synthetic Genomics, Inc., where he continues to push the boundaries of genetic research. His work is characterized by a commitment to advancing the understanding and manipulation of genetic material, which has far-reaching implications in biotechnology and medicine.

Collaborations

Mikkel collaborates with notable colleagues, including Gwynedd A. Benders and John Irvin Glass. These partnerships enhance the innovative potential of his research and contribute to the development of groundbreaking technologies in the field.

Conclusion

Mikkel A. Algire stands out as a key figure in the realm of genome cloning and manipulation. His patents and ongoing work at Synthetic Genomics, Inc. reflect a dedication to advancing genetic engineering, which may lead to significant breakthroughs in various scientific fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…